Answer
Breastfeeding is contraindicated throughout carfilzomib (Kyprolis) treatment and for at least 2 days afterwards, as a risk to the breastfed child cannot be excluded.
Sources for this answer
- KyprolisAmgen Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 21Document updated
Sources checked